Life can change in the blink of an eye. For Alix Schneider, this reality struck during a routine day when an unpredict ...

Colorado physicians helped research a new treatment protocol for the most common form of childhood cancer that has “instantly ...

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...

Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

JERUSALEM: Research released on Wednesday by Israeli and Scottish scientists sheds new light on how cells establish their ...

Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten ...

A round up of some stocks capturing attention this week, featuring INOVIQ, Tamboran Resources, Omni Bridgeway, Clarity Pharmaceuticals and Mesoblast.

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

NEW YORK (WABC) -- A breakthrough is offering good news for cancer patients who lose their hair during chemotherapy. New York ...

After years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host ...